AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MEDICAL DEVELOPMENTS INTERNA

0.460

-0.005-1.08%

Volume:126.31K

Turnover:57.23K

Market Cap:51.82M

PE:575.00

High:0.465

Open:0.465

Low:0.450

Close:0.465

52wk High:0.940

52wk Low:0.420

Shares:112.66M

Float Shares:81.69M

Volume Ratio:0.67

T/O Rate:0.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.001

EPS(LYR):0.001

ROE:0.19%

ROA:0.14%

PB:0.94

PE(LYR):575.00

Loading ...

Overview Company News Filings

BRIEF-Vaxxas Appoints Former Merck Global Vaccines President David Peacock As CEO

Medical Developments International Limited (ASX:MVP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Simply Wall St.

Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market

THOMSON REUTERS

Medical Developments International Limited's (ASX:MVP) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Simply Wall St.

BRIEF-Medical Developments International Posts Group Revenue For Q1FY26 At A$10.9 MLN

BUZZ-Australia's Medical Developments International gains on quarterly revenue growth

Medical Developments International - Group Revenue for Q1 FY26 at a$10.9 Mln

THOMSON REUTERS

Cardano: 1,600 Ideas Head to Vote as Funding Round Takes Off

Medical Developments International Ltd - Gordon Naylor to Step Down as Chair on December 1

THOMSON REUTERS

HPRA Approves Extension of Penthrox Use for Children Aged 6 and Older, Expanding Its Market Reach

BRIEF-Medical Developments International Posts FY Revenue AUD 39.1 Million

Medical Developments International FY Net Income AUD 100 Thousand

THOMSON REUTERS

BRIEF-Medical Developments International Group Posts Revenue For Q4 A$10.2 Million

Medical Developments International Ltd - Group Revenue for Q4 FY25 Was a$10.2 Mln

THOMSON REUTERS

Medical Developments International Ltd-Appendix 4C and Quarterly Activity Report - 30 June 2025

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MVP.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MVP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MVP.AU\",,,,,undefined,":{"symbol":"MVP.AU","market":"AU","secType":"STK","nameCN":"MEDICAL DEVELOPMENTS INTERNA","latestPrice":0.46,"timestamp":1770786720000,"preClose":0.465,"halted":0,"volume":126308,"delay":0,"changeRate":-0.01075268817204302,"nameEN":"MEDICAL DEVELOPMENTS INTERNA","floatShares":81690477,"shares":112658324,"eps":0.0008,"marketStatus":"Not Yet Opened","change":-0.005,"latestTime":"02-11 16:12:00 AEDT","open":0.465,"high":0.465,"low":0.45,"amount":57233,"amplitude":0.032258,"askPrice":0.48,"askSize":30868,"bidPrice":0.46,"bidSize":6036,"shortable":3,"etf":0,"ttmEps":0.0008,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770850800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.465,"openAndCloseTimeList":[[1770764400000,1770786000000]],"volumeRatio":0.6715660053505872,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MVP.AU\",,,,,undefined,":{"symbol":"MVP.AU","floatShares":81690477,"roa":"0.14%","roe":"0.19%","lyrEps":0.0008,"volumeRatio":0.6715660053505872,"shares":112658324,"dividePrice":0,"high":0.465,"amplitude":0.032258,"preClose":0.465,"low":0.45,"week52Low":0.42,"pbRate":"0.94","psRate":"1.33","week52High":0.94,"institutionHeld":0,"latestPrice":0.46,"committee":-0.672881,"eps":0.0008,"divideRate":0,"volume":126308,"delay":0,"ttmEps":0.0008,"open":0.465,"prevYearClose":0.555,"prevWeekClose":0.45,"prevMonthClose":0.47,"prevQuarterClose":0.555,"fiveDayClose":0.485,"twentyDayClose":0.575,"sixtyDayClose":0.58,"dividendPayoutRate":6.922810661128418,"dividendGrowthYears":1,"dividendGrowthRate":1,"fiveYearAvgDividendRate":0.004752121965724171},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MVP.AU\",params:#limit:5,,,undefined,":[{"date":"2025-08-21","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-20","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740006000000,"name":null,"time":"","dateTimestamp":1739970000000,"actualEps":null},{"date":"2024-08-26","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724630400000,"name":null,"time":"","dateTimestamp":1724594400000,"actualEps":null},{"date":"2024-02-29","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709161200000,"name":null,"time":"","dateTimestamp":1709125200000,"actualEps":null},{"date":"2023-08-31","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693440000000,"name":null,"time":"","dateTimestamp":1693404000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MVP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MVP.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601611806","title":"BRIEF-Vaxxas Appoints Former Merck Global Vaccines President David Peacock As CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2601611806","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601611806?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:51","pubTimestamp":1767793867,"startTime":"0","endTime":"0","summary":"BRIEF-Vaxxas Appoints Former Merck Global Vaccines President David Peacock As CEOJan 7 (Reuters) - Medical Developments International Ltd MVP.AX:VAXXAS APPOINTS FORMER MERCK GLOBAL VACCINES PRESIDENT ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA6YKPJL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","LU2361044949.HKD","SG9999015358.SGD","IE00BN8TJ469.HKD","LU0122379950.USD","SG9999002232.USD","IE00BBT3K403.USD","LU1934455863.HKD","LU2361044865.SGD","LU1989771016.USD","LU1934455277.USD","LU1201861249.SGD","LU2089984988.USD","LU0130102774.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","IE0009355771.USD","LU1917777945.USD","SG9999013999.USD","LU2112291526.USD","LU1066051811.HKD","IE00BJJMRZ35.SGD","LU2360032135.SGD","IE000M9KFDE8.USD","LU0211331839.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0320765489.SGD","BK4550","IE00BSNM7G36.USD","LU1116320901.HKD","LU2461242641.AUD","LU1093756325.SGD","LU1162221912.USD","LU1941712264.USD","LU0477156953.USD","BK4007","LU1585245621.USD","LU2125154935.USD","LU1035773651.USD","LU0980610538.SGD","LU0965508806.USD","LU1941712348.USD","LU2023250843.SGD","LU1430594728.SGD","SG9999014567.USD","LU0130517989.USD","IE00BLSP4239.USD","LU0058720904.USD","LU0861579265.USD","LU0098860793.USD","LU1291159041.SGD","SG9999001176.SGD","LU1066051498.USD","LU2468319806.SGD","LU1989772923.USD","LU1699723380.USD","LU0203345920.USD","LU1974910355.USD","LU0238689110.USD","LU0320765646.SGD","LU0965509101.SGD","SG9999001176.USD","BK4588","LU1057294990.SGD","LU1929549753.HKD","BK4516","LU0265550946.USD","SG9999015341.SGD","BK4585","LU1066051225.USD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU0006306889.USD","SG9999001440.SGD","LU2125154778.USD","LU2106854487.HKD","LU0208291251.USD","BK7096","LU1983299246.USD","LU1989772840.SGD","LU0266013472.USD","SG9999014575.USD","LU2361045086.USD","BK4533","LU1061106388.HKD","IE00BLSP4452.SGD","LU2023250504.SGD","LU1069347547.HKD","IE00B1BXHZ80.USD","SG9999002224.SGD","LU1037948897.HKD","SGXZ57979304.SGD","BK4534","LU0265550359.USD","LU0965509010.AUD","LU1037948541.HKD","LU0234572021.USD","LU1116320737.USD","LU0965509283.SGD","LU1093756168.USD","LU0985320562.USD","MVP.AU","LU0106261372.USD","LU0203347892.USD","IE00B2B36J28.USD","BK4559","LU1066053197.SGD","SG9999014542.SGD","LU1571399168.USD","BK7508","LU0070302665.USD","LU0648001328.SGD","SG9999014559.SGD","LU2324357040.USD"],"gpt_icon":0},{"id":"2588709057","title":"Medical Developments International Limited (ASX:MVP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough","url":"https://stock-news.laohu8.com/highlight/detail?id=2588709057","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588709057?lang=en_us&edition=fundamental","pubTime":"2025-12-02 04:04","pubTimestamp":1764619449,"startTime":"0","endTime":"0","summary":"Medical Developments International Limited ( ASX:MVP ) shares have had a horrible month, losing 27% after a relatively...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-mvp/medical-developments-international-shares/news/medical-developments-international-limited-asxmvp-looks-inex","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-mvp/medical-developments-international-shares/news/medical-developments-international-limited-asxmvp-looks-inex","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MVP","BK7508","MVP.AU","BK7096"],"gpt_icon":0},{"id":"2582791488","title":"Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2582791488","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582791488?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:00","pubTimestamp":1762779602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUA9SYCPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MVP.AU","BK7096"],"gpt_icon":0},{"id":"2575396768","title":"Medical Developments International Limited's (ASX:MVP) Share Price Boosted 27% But Its Business Prospects Need A Lift Too","url":"https://stock-news.laohu8.com/highlight/detail?id=2575396768","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575396768?lang=en_us&edition=fundamental","pubTime":"2025-10-16 04:25","pubTimestamp":1760559953,"startTime":"0","endTime":"0","summary":"The Medical Developments International Limited ( ASX:MVP ) share price has done very well over the last month, posting...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-mvp/medical-developments-international-shares/news/medical-developments-international-limiteds-asxmvp-share-pri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-mvp/medical-developments-international-shares/news/medical-developments-international-limiteds-asxmvp-share-pri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7096","BK7508","MVP","MVP.AU"],"gpt_icon":0},{"id":"2574621114","title":"BRIEF-Medical Developments International Posts Group Revenue For Q1FY26 At A$10.9 MLN","url":"https://stock-news.laohu8.com/highlight/detail?id=2574621114","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574621114?lang=en_us&edition=fundamental","pubTime":"2025-10-10 09:36","pubTimestamp":1760060206,"startTime":"0","endTime":"0","summary":"BRIEF-Medical Developments International Posts Group Revenue For Q1FY26 At A$10.9 MLNOct 10 (Reuters) - Medical Developments International Ltd MVP.AX:GROUP REVENUE FOR Q1 FY26 AT A$10.9 MILLIONFurther company coverage: MVP.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nFWN3VQ1AN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MVP.AU","BK7508"],"gpt_icon":0},{"id":"2574311873","title":"BUZZ-Australia's Medical Developments International gains on quarterly revenue growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2574311873","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574311873?lang=en_us&edition=fundamental","pubTime":"2025-10-10 07:18","pubTimestamp":1760051936,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Medical Developments International gains on quarterly revenue growth** Shares of Medical Developments International MVP.AX rise as much as 12% to A$0.700, its biggest intraday gain si","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nL3N3VQ1KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MVP.AU","BK7096"],"gpt_icon":0},{"id":"2574197436","title":"Medical Developments International - Group Revenue for Q1 FY26 at a$10.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2574197436","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574197436?lang=en_us&edition=fundamental","pubTime":"2025-10-10 06:05","pubTimestamp":1760047500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nFWN3VQ1AN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MVP.AU","BK7096"],"gpt_icon":0},{"id":"2569814760","title":"Cardano: 1,600 Ideas Head to Vote as Funding Round Takes Off","url":"https://stock-news.laohu8.com/highlight/detail?id=2569814760","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569814760?lang=en_us&edition=fundamental","pubTime":"2025-09-22 16:31","pubTimestamp":1758529860,"startTime":"0","endTime":"0","summary":"According to Cardano-focused X community account Cardanians, 1,600 ideas head to a vote as a new phase of Cardano's funding mechanism, Project Catalyst, takes off.According to Cardanians, over 1,600 i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/cardano-1600-ideas-head-to-vote-as-funding-round-takes-off","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/cardano-1600-ideas-head-to-vote-as-funding-round-takes-off","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["BK7508","BK7096","MVP","MVP.AU"],"gpt_icon":0},{"id":"2569064302","title":"Medical Developments International Ltd - Gordon Naylor to Step Down as Chair on December 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2569064302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569064302?lang=en_us&edition=fundamental","pubTime":"2025-09-22 14:50","pubTimestamp":1758523814,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250922:nFWN3V70ID:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MVP.AU"],"gpt_icon":0},{"id":"2561986431","title":"HPRA Approves Extension of Penthrox Use for Children Aged 6 and Older, Expanding Its Market Reach","url":"https://stock-news.laohu8.com/highlight/detail?id=2561986431","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561986431?lang=en_us&edition=fundamental","pubTime":"2025-08-21 10:06","pubTimestamp":1755741989,"startTime":"0","endTime":"0","summary":"Medical Developments International Limited  has announced that the Health Products Regulatory Agency  has approved the extension of the indication for Penthrox to include children aged 6 years and older, expanding from the prior indication of 18 years and older. This approval by HPRA, serving as the Reference Member State for the EU Decentralised Procedure , permits national regulatory approval by member states, including Ireland, France, the UK, and several others. The approval also necessitates a device approval due to Penthrox being a combination product. Regulatory approvals across member states are anticipated within the next 12 months. This development follows the successful MAGPIE paediatric trial and is expected to broaden the market for Penthrox, addressing prior entry barriers in select UK ambulance trusts.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, thi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL9pvzpp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MVP.AU"],"gpt_icon":0},{"id":"2561433439","title":"BRIEF-Medical Developments International Posts FY Revenue AUD 39.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2561433439","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561433439?lang=en_us&edition=fundamental","pubTime":"2025-08-21 09:44","pubTimestamp":1755740655,"startTime":"0","endTime":"0","summary":"BRIEF-Medical Developments International Posts FY Revenue AUD 39.1 MillionAug 21 (Reuters) - Medical Developments International Ltd MVP.AX:FY REVENUE AUD 39.1 MILLIONFY NET INCOME AUD 100 THOUSANDFurther company coverage: MVP.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nPLX7F86AD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MVP.AU"],"gpt_icon":0},{"id":"2561889480","title":"Medical Developments International FY Net Income AUD 100 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2561889480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561889480?lang=en_us&edition=fundamental","pubTime":"2025-08-21 06:57","pubTimestamp":1755730646,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nPLX7F86AD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MVP.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"2555107643","title":"BRIEF-Medical Developments International Group Posts Revenue For Q4 A$10.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2555107643","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555107643?lang=en_us&edition=fundamental","pubTime":"2025-07-31 09:31","pubTimestamp":1753925494,"startTime":"0","endTime":"0","summary":"BRIEF-Medical Developments International Group Posts Revenue For Q4 A$10.2 MillionJuly 31  - Medical Developments International Ltd MVP.AX:APPENDIX 4C AND QUARTERLY ACTIVITY REPORT - 30 JUNE 2025GROUP REVENUE FOR Q4 FY25 WAS A$10.2 MILLIONFurther company coverage: MVP.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nTUE5DV4WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MVP.AU"],"gpt_icon":0},{"id":"2555735730","title":"Medical Developments International Ltd -  Group Revenue for Q4 FY25 Was a$10.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2555735730","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555735730?lang=en_us&edition=fundamental","pubTime":"2025-07-31 08:04","pubTimestamp":1753920242,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nTUE5DV4WZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MVP.AU"],"gpt_icon":0},{"id":"2555735270","title":"Medical Developments International Ltd-Appendix 4C and Quarterly Activity Report - 30 June 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2555735270","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555735270?lang=en_us&edition=fundamental","pubTime":"2025-07-31 08:04","pubTimestamp":1753920242,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nTUE5DV4WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MVP.AU","BK7096"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}